Uranus Chemicals Co., LTD. (TPEX:7742)
249.50
+21.00 (9.19%)
At close: Apr 17, 2026
TPEX:7742 Revenue
In the year 2025, Uranus Chemicals Co., LTD. had annual revenue of 1.17B TWD with 42.43% growth. Uranus Chemicals Co., LTD. had revenue of 871.68M in the half year ending December 31, 2025, with 122.56% growth.
Revenue
1.17B
Revenue Growth
+42.43%
P/S Ratio
14.15
Revenue / Employee
10.84M
Employees
108
Market Cap
16.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.17B | 348.74M | 42.43% |
| Dec 31, 2024 | 821.91M | 95.62M | 13.17% |
| Dec 31, 2023 | 726.29M | -591.46M | -44.88% |
| Dec 31, 2022 | 1.32B | 323.82M | 32.58% |
| Dec 31, 2021 | 993.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Taiwan Semiconductor | 17.95B |
| Feastogether Group | 11.68B |
| Anpec Electronics | 7.48B |
| Synmosa Biopharma | 6.19B |
| Ability Opto-Electronics Technology | 4.32B |
| Brillian Network & Automation Integrated System | 2.58B |
| ASRock Industrial Computer | 1.83B |
| Phoenix Pioneer technology | 1.46B |